Subcellular Localization and Quantification of Androgen Receptor in Hormone-Naive Prostatic Adenocarcinoma and Clinical Correlation

被引：0
|
作者：
Huang, W.
Hoyt, C.
Pier, T.
Fletcher-Holmes, D.
机构：
[1] Univ Wisconsin Madison, Madison, WI USA
[2] Cambridge Res & Instrumentat Inc, Woburn, MA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
838
引用
收藏
页码：199A / 199A
页数：1
相关论文
共 50 条
  • [31] Zoledronic Acid Improves Clinical Outcomes in Patients with Bone Metastatic Hormone-naive Prostate Cancer in a Multicenter Clinical Trial
    Okegawa, Takatsugu
    Higaki, Masao
    Matsumoto, Tetsuo
    Kase, Hiroshi
    Murata, Akihiro
    Noda, Kenjiro
    Noda, Haruhisa
    Asaoka, Hiroshi
    Oshi, Masaya
    Tomoishi, Junzo
    Uchida, Hiroji
    Higashihara, Eiji
    Nutahara, Kikuo
    ANTICANCER RESEARCH, 2014, 34 (08) : 4415 - 4420
  • [32] METASTATIC PROSTATIC ADENOCARCINOMA - ANDROGEN DEPRIVATION - INFLUENCE ON THE CLINICAL COURSE OF DISSEMINATED DISEASE
    HATCHER, PA
    ANDERSON, EE
    JOURNAL OF UROLOGY, 1987, 137 (04): : A361 - A361
  • [33] Androgen deprivation therapy with chemotherapy or abiraterone for patients with metastatic hormone-naive prostate cancer: a systematic review and meta-analysis
    Sun, Guijiang
    Chen, Xuanrong
    Gong, Xue
    Chen, Yawei
    Li, Guilai
    Wei, Fang
    Jiang, Aili
    Niu, Yuanjie
    Shang, Zhiqun
    FUTURE ONCOLOGY, 2019, 15 (10) : 1167 - 1179
  • [34] Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy
    vanderKwast, TH
    Tetu, B
    Fradet, Y
    Dupont, A
    Gomez, J
    Cusan, L
    Diamond, P
    Labrie, F
    PROSTATE, 1996, 28 (04): : 227 - 231
  • [35] Expression of estrogen receptor alpha and beta, androgen receptor, and glutathione-s-transferase π in prostatic adenocarcinoma
    Ronchetti, RD
    Torres-Cabala, C
    Chian-Garcia, CA
    Duray, PH
    Phillips, J
    Linehan, WM
    MODERN PATHOLOGY, 2003, 16 (01) : 167A - 167A
  • [36] Expression of estrogen receptor alpha and beta, androgen receptor, and glutathione-s-transferase π in prostatic adenocarcinoma
    Ronchetti, RD
    Torres-Cabala, CA
    Chian-Garcia, CA
    Duray, PH
    Phillips, J
    Linehan, WM
    LABORATORY INVESTIGATION, 2003, 83 (01) : 167A - 167A
  • [37] The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells
    Wetherill, YB
    Petre, CE
    Monk, KR
    Puga, A
    Knudsen, KE
    MOLECULAR CANCER THERAPEUTICS, 2002, 1 (07) : 515 - 524
  • [38] Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: Prognostic implications
    Theodoropoulos, VE
    Tsigka, A
    Mihalopoulou, A
    Tsoukala, V
    Lazaris, AC
    Patsouris, E
    Ghikonti, I
    UROLOGY, 2005, 66 (04) : 897 - 902
  • [39] Long-term Efficacy and Safety Results: Can Enzalutamide Challenge the Dogma of Androgen Deprivation Therapy in Hormone-naive Prostate Cancer?
    Albiges, Laurence
    Loriot, Yohann
    Massard, Christophe
    Fizazi, Karim
    EUROPEAN UROLOGY, 2015, 68 (05) : 802 - 804
  • [40] STAMPEDE-ing towards androgen biosynthesis inhibition for treatment of high-risk hormone-naive prostate cancer: changing the LATITUDE
    Klaassen, Zachary
    Murphy, Declan G.
    BJU INTERNATIONAL, 2018, 121 (01) : 9 - 11
12345